Vaxcell Bio Therapeutics
KOSDAQ:323990
Shareholder Yield
Current shareholder yield for Vaxcell Bio Therapeutics is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
Price
Vaxcell Bio Therapeutics
| Average Annual Return | -40.63% |
| Standard Deviation of Annual Returns | 18.56% |
| Max Drawdown | -94% |
| Market Capitalization | 195.1B KRW |
| Shares Outstanding | 23 260 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Vaxcell Bio Therapeutics's latest stock split occurred on Nov 10, 2023
The company executed a 6-for-5 stock split, meaning that for every 5 shares held, investors received 6 new shares.
Before the split, Vaxcell Bio Therapeutics traded at 23999.9908 per share. Afterward, the share price was about 21250.
The adjusted shares began trading on Nov 10, 2023. This was Vaxcell Bio Therapeutics's 3rd stock split, following the previous one in Sep 20, 2023.
